ArticleAesthetic plastic surgery2025
Hypoxia-Preconditioned Adipose Stem Cell Exosomes Promote Adipose Graft Vascular Regeneration via miRNA-126.
Article in Aesthetic plastic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- A bioadhesive antioxidant dual-crosslinked hydrogel mitigates endothelial pyroptosis to enhance ischemic flap survival.Journal of nanobiotechnology · 2026Article
- Plant Exosome Injections in Tongue Wounds: A Comparative Histological and Immunohistochemical Experimental Study.Plastic and reconstructive surgery. Global open · 2026Article
- The Immunologic Spectrum of Biostimulators and Its Clinical Importance.Plastic and reconstructive surgery. Global open · 2025Article
- Amelioration of pregnancy outcomes in a pregnant rat model with deep venous thrombosis following the transplantation of bone marrow mesenchymal stem cells.Frontiers in cell and developmental biology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
BACKGROUND AND
objectiveAdipose-derived mesenchymal stem cell-derived extracellular vesicles (ASCs-Exos) possess angiogenic potential, which can enhance the retention rate of fat grafts. Hypoxic preconditioning can augment their functionality. However, the optimal conditions for hypoxic preconditioning and the specific mechanisms by which it exerts its effects are not well defined. This study aimed to screen for the optimal hypoxic culture conditions for ASCs and to preliminarily elucidate the mechanisms by which they exert their effects.
methodsFlow cytometry and TUNEL fluorescence staining were employed to determine the optimal oxygen concentration and culture duration for hypoxic preconditioning of ASCs-Exos. Subsequently, a mixture of human adipose tissue and hypoxic preconditioned ASCs-Exos was implanted into the subcutaneous fat of nude mice. At 4 and 12 weeks post-transplantation, the fat graft specimens were weighed, and hematoxylin and eosin (H&E) staining and immunohistochemistry were performed to examine the samples. The expression of CD31 was assessed to analyze the formation of neovascularization. The expression of miRNA in Exos was then detected, and the influence of ASCs-Exos derived miRNA-126 on the proliferative capacity of neovascularization was verified through an EDU fluorescence assay.
resultsASCs-Exos exhibited optimal performance when cultured under an oxygen concentration of 5% for 24 h. After transplantation of human adipose tissue mixed with hypoxic preconditioned ASCs-Exos for 4 to 12 weeks, the weight of fat grafts and the number of viable adipocytes in the hypoxic ASCs-Exos group were significantly higher than those in the control group (P < 0.05), with better adipocyte integrity and enhanced neovascularization capacity. Detection of miRNA derived from hypoxic preconditioned ASCs-Exos revealed that miRNA-126 demonstrated robust angiogenic and proliferative capabilities in both in vitro and in vivo experiments.
conclusionsIn summary, hypoxic preconditioning of ASCs-Exos at 5% oxygen for 24 h significantly enhances their angiogenic properties, thereby improving the viability and retention of fat grafts. The study elucidates miRNA-126 as a critical mediator of neovascularization and adipocyte survival, offering a promising avenue for enhancing the efficacy of ASCs-Exos in regenerative medicine. NO LEVEL ASSIGNED: This journal requires that authors assign a level of evidence to each submission to which Evidence-Based Medicine rankings are applicable. This excludes Review Articles, Book Reviews, and manuscripts that concern Basic Science, Animal Studies, Cadaver Studies, and Experimental Studies. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Indexed as
Identifiers
39762395What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.